Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

3-D Protein Snapshot Highlights Potential Drug Target for Breast Cancer

March 18, 2015 11:18 am | by University of Vermont | News | Comments

The genome of a cell is under constant attack, suffering DNA damage that requires an army of repair mechanisms to keep the cell healthy and alive. Understanding the behavior of the enzymes defending these assaults helps determine how - and where - cancer gets its foothold and flourishes. Read more...


Study Suggests Precision Medicine for Adrenal Cancer

March 18, 2015 10:57 am | by University of Michigan | News | Comments

Despite overall lack of success, small subset of patients responds to investigational drug. Read more...


Breast Biopsy Accuracy is Questioned in Experimental Study

March 18, 2015 10:41 am | by By Lindsey Tanner, AP Medical Writer | News | Comments

Here's another reason for getting a second medical opinion: Biopsy specialists frequently misdiagnose breast tissue, potentially leading to too-aggressive treatment for some women and under-treatment for others, a study suggests. Read more...


Where is the Money in Biosimilars?

March 18, 2015 9:11 am | by Daniel N. Galbraith, Ph.D., BioOutsource Ltd | Articles | Comments

In the past 10 years biosimilars have held strong in the biologics industry’s headlines. These products were once thought impossible to approve in regulated markets because the sheer complexity of producing these large, complex proteins can result in “robustness” issues. Read more...


Actavis Completes Acquisition of Allergan

March 18, 2015 9:09 am | News | Comments

The deal is valued at approximately $70.5 billion.


Potential Drug Target Found to Prevent Bowel Cancer Spread

March 18, 2015 9:03 am | by Monash University | News | Comments

Scientists have discovered a molecule that is crucial to the survival of stem cells in the intestine. Read more...


Roche Launches Next-Generation Duplex Test for Parovirus B19, Hepatitis A

March 18, 2015 8:56 am | News | Comments

This test is only available in markets accepting the CE mark. Read more...


Emerging Diseases Likely to be More Harmful in Similar Species

March 18, 2015 8:49 am | by University of Cambridge | News | Comments

Research shows that it may be possible to predict the virulence of a virus by looking at how deadly it is in closely-related species. Read more...


New Hope for Kidney Disease

March 18, 2015 8:43 am | by Monash University | News | Comments

Researchers have made a discovery that could see patients with kidney disease no longer having to resort to dialysis or kidney transplants. Read more...


Study: Euthanasia Cases More Than Double in Northern Belgium

March 18, 2015 8:40 am | by Raf Casert, Associated Press | News | Comments

Almost one in 20 people in northern Belgium died using euthanasia in 2013, more than doubling the numbers in six years. Read more...


Prices of Cancer Drugs Have Soared Since 1995: Study

March 17, 2015 12:43 pm | by Peter Dizikes, MIT News | News | Comments

The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist — but the exact reasons for the cost increases are unclear. Read more...


U.S. Pharmaceutical Market Value Will Approach $550 Billion by 2020: GlobalData

March 17, 2015 12:31 pm | News | Comments

The U.S. pharmaceutical market is forecast to increase from an estimated value of $395.2 billion in 2014 to reach $548.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.6 percent, according to research and consulting firm GlobalData. Read more..


Mississippi Wants Execution-Drug Supplier's Name Kept Secret

March 17, 2015 12:25 pm | by Jeff Amy - Associated Press | News | Comments

Mississippi's attorney general is asking a judge to keep the identity of the state's execution-drug supplier secret while he appeals her order to release the name. Read more....


23andMe FDA Approval Clears Way for More Sequencing-Based Tests

March 17, 2015 12:17 pm | News | Comments

​Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the way for more genetic tests sold to consumers or prescribed by doctors that use next-generation sequencing technology. Read more...


Potential Treatment for Most Common Form of Muscular Dystrophy

March 17, 2015 12:02 pm | by University of Virginia Health System | News | Comments

A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could slow progression of muscle damage and muscle dysfunction associated with the disease – issues that cause patients significant disability and deterioration in quality of life. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.